Yahoo
NasdaqCM - Nasdaq Real Time Price USD

Inhibikase Therapeutics, Inc. (IKT)

1.5500 -0.1200 (-7.19%)
At close: October 30 at 4:00:00 PM EDT
1.5500 0.0000 (0.00%)
After hours: October 30 at 4:00:16 PM EDT
Trade IKT on Coinbase
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
0
0
0
0
0
Operating Expense
65,660.9250
53,348.2250
28,589.0680
20,089.7920
18,128.6080
Operating Income
-65,660.9250
-53,348.2250
-28,589.0680
-20,089.7920
-18,128.6080
Net Non Operating Interest Income Expense
4,799.9110
3,715.0940
1,069.1820
1,060.9090
74.4530
Other Income Expense
224.0120
1,373.9420
--
--
--
Pretax Income
-60,637.0020
-48,259.1890
-27,519.8860
-19,028.8830
-18,054.1550
Net Income Common Stockholders
-60,637.0020
-48,259.1890
-27,519.8860
-19,028.8830
-18,054.1550
Diluted NI Available to Com Stockholders
-60,637.0020
-48,259.1890
-27,519.8860
-19,028.8830
-18,054.1550
Basic EPS
-0.44
-0.49
-1.16
-3.16
-4.28
Diluted EPS
-0.44
-0.49
-1.16
-3.16
-4.28
Basic Average Shares
140,145.5850
98,310.1900
23,712.2200
6,028.2100
4,223.0990
Diluted Average Shares
140,145.5850
98,310.1900
23,712.2200
6,028.2100
4,223.0990
Total Operating Income as Reported
-65,436.9130
-51,974.2830
-28,589.0680
-20,089.7920
-18,128.6080
Total Expenses
65,660.9250
53,348.2250
28,589.0680
20,089.7920
18,128.6080
Net Income from Continuing & Discontinued Operation
-60,637.0020
-48,259.1890
-27,519.8860
-19,028.8830
-18,054.1550
Normalized Income
-60,861.0140
-49,633.1310
-27,519.8860
-19,028.8830
-18,054.1550
Interest Income
4,799.9110
3,715.0940
1,069.1820
1,060.9090
74.4530
Net Interest Income
4,799.9110
3,715.0940
1,069.1820
1,060.9090
74.4530
EBIT
-65,660.9250
-53,348.2250
-28,589.0680
-20,089.7920
-18,128.6080
EBITDA
-65,637.2380
-53,287.7260
-28,562.7960
-19,912.3940
-18,121.8850
Reconciled Depreciation
23.6870
60.4990
26.2720
177.3980
6.7230
Net Income from Continuing Operation Net Minority Interest
-60,637.0020
-48,259.1890
-27,519.8860
-19,028.8830
-18,054.1550
Total Unusual Items Excluding Goodwill
224.0120
1,373.9420
0
--
--
Total Unusual Items
224.0120
1,373.9420
0
--
--
Normalized EBITDA
-65,861.2500
-54,661.6680
-28,562.7960
-19,912.3940
-18,121.8850
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2022 - 12/23/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: